Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M.C. Liebl
Identification of Responders to Immune Checkpoint Therapy: Which Biomarkers Have the Highest Value?
Journal of the European Academy of Dermatology and Venereology
Dermatology
Infectious Diseases
Related publications
Immune Checkpoint Therapy and the Search for Predictive Biomarkers
Cancer Journal
Cancer Research
Oncology
Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
Frontiers in Immunology
Allergy
Immunology
The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy
Clinical Cancer Research
Cancer Research
Oncology
Hypokalemic Paralysis Secondary to Immune Checkpoint Inhibitor Therapy
Case Reports in Oncological Medicine
Oncology
Biomarkers for Immune Checkpoint Inhibitors: The Importance of Tumor Topography and the Challenges to Cytopathology
Cancer cytopathology
Cancer Research
Oncology
On the Mechanism of Anti-Cd39 Immune Checkpoint Therapy
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Neutrophil Lymphocyte Ratio and Duration of Prior Anti-Angiogenic Therapy as Biomarkers in Metastatic RCC Receiving Immune Checkpoint Inhibitor Therapy
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Current Landscape and Future Directions of Biomarkers for Predicting Responses to Immune Checkpoint Inhibitors
Cancer Management and Research
Oncology
Systemic Immunological Biomarkers of Clinical Responses in Immune Checkpoint Blockade Therapies
Lung Cancer Management
